Fundraising Fox

Marco Boorsma

Investor

General Partner at Forbion

Amsterdam, Netherlands

Writes $100K – $5M checks · typically $1.5M

About

Marco Boorsma is a General Partner at Forbion, which he joined in 2007. Before Forbion, he was Business Development Director at DSM Pharmaceutical Products and worked on manufacturing processes for biosimilars at Cytos Biotechnology. He focuses on biotechnology, operations, and business development, with an emphasis on founding and managing new companies as part of Forbion's build strategy, and holds an MSc in Molecular Biology from the University of Groningen and a PhD in Biotechnology from ETH Zürich.

Invests in

Biotech

Experience

  1. ForbionGeneral Partnercurrent2017 — presentNaarden, The Netherlands
  2. ForbionPartner2014 — 2017Naarden, The Netherlands
  3. ForbionPrincipal2010 — 2014
  4. ForbionSenior Analyst2007 — 2010Naarden
  5. Calluna PharmaBoard Director at Calluna Pharmacurrent2024 — presentOslo, Norway
  6. Sitala BioBoard Director at Sitalacurrent2021 — presentCambridge, England, United Kingdom
  7. Rectify PharmaBoard Director at Rectify Pharmacurrent2021 — presentCambridge, Massachusetts, United States
  8. VectorYBoard Director at VectorY2021 — 2025Amsterdam, North Holland, Netherlands
  9. VectorYChief Executive Officer2020 — 2021Amsterdam, North Holland, Netherlands
  10. Oxitope PharmaChairman of the Board2020 — 2023Naarden, North Holland, Netherlands
  11. Engene Inc.Board Director at enGene2017 — 2023Montreal, Canada
  12. Inversago PharmaBoard Director at Inversago2020 — 2023Montreal, Quebec, Canada
  13. Escalier Biosciences B.V.Board Director at Escalier Biosciences2018 — 2023Nijmegen, The Netherlands
  14. Inflazome LtdBoard Director at Inflazome2018 — 2020Dubline, Ireland
  15. NorthSea TherapeuticBoard Director at NorthSea Therapeutics2017 — 2019Naarden, The Netherlands
  16. Milestone Pharmaceuticals, Inc.Board Director at Milestone Pharmaceuticals2017 — 2019Greater Montreal Metropolitan Area
  17. Exosome DiagnosticsObserver to the BoD2010 — 2018Cambridge, USA
  18. Prexton Therapeutics SABoard Director at Prexton Therapeutics2017 — 2018Netherlands
  19. RSPR Pharma ABBoard Director at RSPR Pharma2014 — 2018Greater Stockholm Metropolitan Area
  20. OxyraneObserver to the BoD2011 — 2017Manchester Area, United Kingdom

Education

  1. ETH ZürichPhD, Biotechnology1998 — 2001
  2. University of GroningenBS, Molecular Biology1993 — 1998

Skills & more

Strategy3Venture Capital12Contract Manufacturing3Biotechnology29Molecular Biology11Biochemistry5Clinical Development9Cell Culture6Lifesciences3Biopharmaceuticals3Licensing2Business Development3
+12 moreR&DPharmaceutical IndustryDrug DevelopmentStart-upsPatentsIntellectual PropertyVaccinesValidationEntrepreneurshipImmunologyMergers & AcquisitionsMedical Devices

From Marco's professional profile.

Deals · 1

Milestone PharmaceuticalsBoard seat

via Forbion · filed Jul 2017 · $6.9M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Forbion

Network1

Investors connected to Marco in public investor directories — a warm-intro map.

Frequently asked questions

Where does Marco Boorsma work?
Marco Boorsma is General Partner at Forbion.
What does Marco Boorsma invest in?
Marco Boorsma invests in Biotech.
What check size does Marco Boorsma write?
Marco Boorsma typically writes checks of $100K – $5M.

Same school

Shared employers